tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ovid Therapeutics sees cash runway into 2H26

Cash, cash equivalents and marketable securities as of March 31, 2025 totaled $43.0 million.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1